Biohaven Pharmaceutical Holding Company Ltd.

DB:2VN 株式レポート

時価総額:€11.0b

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

このページの翻訳は実験的なもので、現在開発中です。お待ちしております

Biohaven Pharmaceutical Holding 所有権

大株主は誰で、インサイダーは売買しているのか?


最近のインサイダー取引

インサイダー取引量

インサイダー購入: 2VN insiders have bought more shares than they have sold in the past 3 months.


所有権の内訳

2VN の所有者構成は?
オーナータイプ株式数所有比率
民間企業1,111,1111.55%
個人インサイダー6,653,0879.31%
一般市民7,102,0549.93%
機関56,628,54679.2%

株式の希薄化: Shareholders have been diluted in the past year, with total shares outstanding growing by 9.3%.


上位株主

25 上位株主59.07 %を所有。
所有権名称株式現在の価値変化率ポートフォリオ
7.09%
BlackRock, Inc.
5,072,075€779.4m8.92%0.02%
5.93%
Capital Research and Management Company
4,236,237€651.0m-55%0.05%
4.3%
Stifel Asset Management Corp.
3,071,839€472.0m0.78%0.77%
4.25%
Adage Capital Management, L.P.
3,039,092€467.0m1,500%1.1%
4.25%
John Childs
3,035,001€466.4m0%データなし
3.61%
Gregory Bailey
2,583,658€397.0m0%データなし
2.7%
Marshall Wace LLP
1,928,624€296.4m-19.7%0.8%
2.44%
State Street Global Advisors, Inc.
1,745,046€268.2m5.39%0.02%
2%
The Vanguard Group, Inc.
1,432,458€220.1m0.75%0.01%
2%
Pentwater Capital Management LP
1,430,000€219.7m0%4.09%
1.76%
Soros Fund Management LLC
1,255,001€192.8m0%5.16%
1.74%
Oracle Investment Management, Inc.
1,240,932€190.7m-39.8%61.46%
1.58%
Eventide Asset Management, LLC
1,129,100€173.5m-30.9%3.49%
1.55%
RP Management LLC
1,111,111€170.7m0%データなし
1.5%
Janus Henderson Group plc
1,075,466€165.3m-60.3%0.09%
1.5%
Geode Capital Management, LLC
1,072,125€164.7m6.72%0.02%
1.44%
TIG Advisors, LLC
1,029,868€158.3m0%7.86%
1.42%
BNY Mellon Asset Management
1,015,177€156.0m-12.1%0.04%
1.29%
Vladimir Coric
922,941€141.8m0.02%データなし
1.27%
Allspring Global Investments, LLC
910,892€140.0m-60.3%0.22%
1.26%
Knoll Capital Management
900,844€138.4m0%75.88%
1.16%
ClearBridge Investments, LLC
830,776€127.7m-27.9%0.12%
1.04%
Brown Advisory Incorporated
746,074€114.6m-12.6%0.2%
1.01%
OrbiMed Advisors LLC
719,034€110.5m0%1.86%
0.98%
Versor Investments LP
698,793€107.4m0%5.34%